Furthermore, we found that CRGs were correlated with the expression of PD-1, PD-L1, and CTLA4, which implies possible effects on regulating the immune escape and TIM, and may be promising targets to improve the efficacy of immunotherapy in HCC. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.